Drugs & Therapy Perspectives

, Volume 16, Issue 10, pp 1–4 | Cite as

Lyme disease vaccine: a tick for prevention

New drugs and disease management
  • 16 Downloads

Keywords

Chronic Lymphocytic Leukaemia Lyme Disease Booster Dose Borrelia Burgdorferi Vaccination Schedule 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Centers for Disease Control and Prevention. Lyme disease: United States, 1996. MMWR 1997; 46(23): 531–5Google Scholar
  2. 2.
    Recommendations for the use of Lyme disease vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999 Jun 4; 48 Suppl. RR-7: 1-26Google Scholar
  3. 3.
    Onrust SV, Goa KL. Adjuvanted Lyme disease vaccine: a review of its use in the management of Lyme disease. Drugs 2000 Feb; 59(2): 281–299PubMedCrossRefGoogle Scholar
  4. 4.
    Steere AC, Sikand VK, Meurice F, et al. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer surface lipoprotein A with adjuvant. N Eng J Med 1998 Jul 23; 339: 209–215CrossRefGoogle Scholar
  5. 5.
    Van Hoecke C, Lebacq E, Beran J, et al. Alternative vaccination schedules (0, 1 and 6 months versus 0, 1 and 12 months) for a recombinant OspA Lyme disease vaccine. Clin Infect Dis 1999 Jun; 28: 1260–4PubMedCrossRefGoogle Scholar
  6. 6.
    Feder Jr HM, Beran J, Van Hoecke C, et al. Immunogenicity of recombinant Borrelia burgdorferi outer surface protein A vaccine against Lyme disease in children. J Pediatr 1999; 135: 575–9PubMedCrossRefGoogle Scholar
  7. 7.
    Beran J, Dieussaert I, Van Hoecke C, et al. Reactogenicity and immunogenicity of LYMErix, the Lyme disease vaccine, in healthy children aged 2–5 years [abstract no. P219]. Eighth International Conference on Lyme borreliosis and other emerging tick-borne diseases: 1999 Jun 20–24; Munich: 60Google Scholar
  8. 8.
    Sigal LH. Lyme arthritis: lessons learned and to be learned. Arthritis Rheum 1999 Sep; 42(9); 1809–12PubMedCrossRefGoogle Scholar
  9. 9.
    Meltzer MI, Dennis DT, Orloski KA. The cost effectiveness of vaccinating against Lyme disease. Emerg Infect Dis 1999 May–Jun; 5(3): 321–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 2000

Personalised recommendations